Feeds:
Posts
Comments

Search Results for 'Peripheral'


Spectranetics, a Technology Leader in Medical Devices for Coronary Intervention, Peripheral Intervention, Lead Management to be acquired by Philips for 1.9 Billion Euros Reporter and Curator: Aviva Lev-Ari, PhD, RN     BUSINESS NEWS | Wed Jun 28, 2017 | 10:53am BST Philips to buy medical device maker Spectranetics for 1.9 billion euros By Toby Sterling […]

Read Full Post »


Advanced Peripheral Artery Disease (PAD): Axillary Artery PCI for Insertion and Removal of Impella Device Reporter: Aviva Lev-Ari, PhD, RN     TOTALLY PERCUTANEOUS INSERTION AND REMOVAL OF IMPELLA DEVICE USING AXILLARY ARTERY IN THE SETTING OF ADVANCED PERIPHERAL ARTERY DISEASE July 15, 2016 Authors: Rajiv Tayal, MD, MPH1,2;  Mihir Barvalia, MD, MHA1;  Zeshan Rana, […]

Read Full Post »


AGENDA – ICI Meeting 2015 – International Conference for Innovations in Cardiovascular Systems (Heart, Brain and Peripheral Vessels) and High-Tech Life Science Industry, December 13-15, 2015, David InterContinental Hotel, Tel Aviv, Israel Reporter: Aviva Lev-Ari, PhD, RN WELCOME LETTER Dear Colleagues, It is with great pleasure that we invite you to the ICI Meeting 2015, […]

Read Full Post »


Veins Construction using Autologous Peripheral Whole Blood Reporter: Aviva Lev-Ari, PhD, RN In vivo application of tissue-engineered veins using autologous peripheral whole blood: A proof of concept study Michael Olaussona, 1, Vijay Kumar Kunaa, 1, Galyna Travnikovaa, Henrik Bäckdahlb, Pradeep B. Patila, Robert Saalmanc, Helena Borgc, Anders Jeppssond, Suchitra Sumitran-Holgerssona a Department of Surgery, University of Gothenburg, Sahlgrenska […]

Read Full Post »


Author: Tilda Barliya PhD Peripheral nerve lacerations are common injuries and often cause long lasting disability (1a) due to pain, paralyzed muscles and loss of adequate sensory feedback from the nerve receptors in the target organs such as skin, joints and muscles (1b). Nerve injuries are common and typically affect young adults with the majority of injuries occur from […]

Read Full Post »


Positioning a Therapeutic Concept for Endogenous Augmentation of cEPCs — Therapeutic Indications for Macrovascular Disease: Coronary, Cerebrovascular and Peripheral Author and Investigator Initiated Study: Aviva Lev-Ari, PhD, RN   Macrovascular Disease – Therapeutic Potential of cEPCs: Promise for CV Risk Reduction Introduction Biomarker Discovery – a comprehensive Post on this topic is forthcoming What are our […]

Read Full Post »


Noam Steiner Tomer, Summer Internship, Research Assistant 1 https://pharmaceuticalintelligence.com/contributors-biographies/research-assistants/noam-steiner-tomer-summer-internship-research-assistant-1/ 7/3/2020 Leukemia and Lymphoma Mutations Title Gene(s) Imatinib (Gleevec) May Help Treat Aggressive Lymphoma: Chronic Lymphocytic Leukemia (CLL) ABL/BCR, p53, 17q Sunitinib brings Adult Acute Lymphoblastic Leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade FLT3 Metabolomic analysis of two leukemia cell lines. II. ZAP-70(+), […]

Read Full Post »


COVID-19: Novel Treatment Protocols using Approved drugs vs Standard of Care vs Vaccine and Antiviral new drug discovery and development – An LPBI Group Response and An LPBI Group & Affiliates Response Curator: Aviva Lev-Ari, PhD, RN   On 5/26/2020 LPBI organized a Symposium on New Therapeutics for COVID-19 AGENDA included presentations by: Dr. Raphael […]

Read Full Post »


Live Notes, Real Time Conference Coverage 2020 AACR Virtual Meeting April 27, 2020 Minisymposium on Drugging Undrugged Cancer Targets 1:30 pm – 5:00 pm SESSION VMS.ET01.01 – Drugging Undrugged Cancer Targets April 27, 2020, 1:30 PM – 3:30 PM Virtual Meeting: All Session Times Are U.S. EDT Session Type Virtual Minisymposium Track(s) Experimental and Molecular Therapeutics,Drug […]

Read Full Post »


My Memories Tell a Story to Share Author: Larry Howard Bernstein, MD, FCAP  Contact: 413-727-8523   Updated on 6/2/2020 In preparation for a PODCAST with Dr. Larry, we prepared the following content: For many years, he was the Chief Scientific Officer and Member of the Board of Leaders in Pharmaceutical Business Intelligence (LPBI) Group, a […]

Read Full Post »

Next »